The chemical structure of phenothiazine provides a most valuable molecular template for the development of agents able to interact with a wide variety of biological processes. Synthetic phenothiazines (with aliphatic, methylpiperazine, piperazine-ethanol, piperazine-ethyl, or piperidine side-chain) and/or phenothiazine-derived agents e.g., thioxanthenes, benzepines, imonostilbenes, tricyclic antidepressants, dimetothiazine, and cyproheptadine have been effective in the treatment of a number of medical conditions with widely different etiology. These include various currently clinically used drugs for their significant antihistamic, antipsychotic, anticholinergic (antiparkinson), antipruritic, and/or antiemetic properties. They are also employed, although to a minor extent, as antidepressants, antispasmodics, analgesics, and antiarrhythemics. Some of these agents are also useful as anti-inflammatory, coronary vasodilator, radioprotective, sedative, antitussive, and skeletal muscle-relaxing medication. Still, others show different degrees of effectiveness as antibacterials, anthelmintics, antimalarials, or local anesthetics; a few are valuable in the control of acute migraine attacks and intractable hiccough. Adding to the seemingly ever-expanding therapeutic use of phenothiazine derivatives, a number of "old" and newly synthesized compounds e.g., "half-mustard-type" and benzo[alpha]phenothiazines, appear to be helpful as multidrug resistance modifiers, a property of particular importance in cancer chemotherapy. Some phenothiazines inhibit human plasmatic leucine-enkephalin aminopeptidase(s), enzymes known to regulate the turnover rate of a wide range of bioactive substances. These findings could lead to the design of new therapeutic treatment modalities for conditions such as Alzeimer's and Creutzfeldt-Jakob disease. Hopefully, this work will help to the rational design of new and improved pharmacological approaches based on a better understanding of the correlation between chemical structure, pharmacodynamic properties, and pharmacological activity of various phenothiazines and phenothiazine-derived classes of drugs.
Review American journal of therapeutics. 2006 May-Jun;13(3):261-73. doi: 10.1097/01.mjt.0000212897.20458.63 Q32.52025
Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents
芬太azine分子为各类药物提供了基本的化学结构 翻译改进
作者单位 +展开
作者单位
DOI: 10.1097/01.mjt.0000212897.20458.63 PMID: 16772768
摘要 Ai翻译
相关内容
-
Pharmacotherapeutic agents in the treatment of methamphetamine dependence
用于治疗甲基苯丙胺依赖的药物疗法
Expert opinion on investigational drugs. 2017 May;26(5):563-578.
-
Phenothiazine: the parent molecule
吩噻嗪:母体分子
Current drug targets. 2006 Sep;7(9):1181-9.
-
Pharmacotherapeutic agents in xenotransplantation
药物治疗在异种移植中的应用
Expert opinion on pharmacotherapy. 2000 May;1(4):757-69.
-
Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm
心力衰竭的当前和未来药物治疗:一个不断发展的范式
British journal of pharmacology. 2016 Jun;173(12):1911-24.
-
Pharmacotherapeutic agents used in temporomandibular disorders
用于颞下颌关节紊乱的药物治疗剂
Oral diseases. 2014 Nov;20(8):740-3.
-
Review: pharmacotherapeutic agents in the treatment of portal hypertension
用药治疗门静脉高压症的研究进展
Journal of gastroenterology and hepatology. 1997 Feb;12(2):159-66.
-
Marine Depsipeptides as Promising Pharmacotherapeutic Agents
有前景的海洋多肽 depsipeptide 药物治疗剂
Current protein & peptide science. 2017;18(1):72-91.
-
Herbal formulations as pharmacotherapeutic agents
草药配方作为药物治疗制剂
Indian journal of experimental biology. 2002 Jan;40(1):7-11.